The report contains ten-year analysis with the following sections
contact us for pricing
Check out our sample pages |
Many companies now available
Search to find companies of interest
read summary of their published patent
the company report contains more information
vascular biogenics | 423 |
vask'jular bajodzheniks | 2 |
canalis-haemalis biogrowth | 1 |
cardimmune | 1 |
vascular biogenics | 31 |
vask'jular bajodzheniks | 1 |
vascular biogenics | 22 |
Title of patent family (most common patent title) |
Family members |
Filing year |
---|---|---|
methods for use of a specific anti-angiogenic adenoviral agent | 46 | 2010 |
promoters exhibiting endothelial cell specificity and methods of using same | 39 | 2000 |
oxidized lipid compounds and uses thereof | 34 | 2008 |
improved process for the preparation of oxidized phospholipids | 32 | 2004 |
treatment methods using adenovirus | 29 | 2012 |
improved process for the preparation of oxidized phospholipids | 28 | 2004 |
promoters exhibiting endothelial cell specificity and methods of using same for regulati… 🛈 | 26 | 2000 |
formulations and dosage forms of oxidized phospholipids | 24 | 2011 |
oxidized lipids and uses thereof in the treatment of inflammatory diseases and disorders | 22 | 2000 |
treatment with vb-201 | 21 | 2010 |